A Heparin-Induced Thrombocytopenia with Thrombosis in Coronary Artery Bypass Grafts Can Be Fatal: A Case Report.
The Egyptian Journal of Cardiothoracic Anesthesia · 2024
DOI: 10.21608/ejca.2024.388897 ↗Kurz gefasst
Fallbericht in der Zeitschrift The Egyptian Journal of Cardiothoracic Anesthesia, 2024. Verfasst von Arumugam Arunkumar und 6 weiteren Autor:innen.
Abstract (Originalsprache)
Heparin is the preferred anticoagulant for cardiac surgery because of its easy availability, monitoring and reversibility. Afew set of patients who are exposed to heparin in the past have a risk of developing heparin-induced thrombocytopeniawhich can be dreadful while undergoing any cardiac interventions.
Zitieren
APA
Arunkumar, A., Kishore, R., Rajeev, T., Mohammed, I., Mohammed, I., Jacob, A., & Bashi, V. (2024). A Heparin-Induced Thrombocytopenia with Thrombosis in Coronary Artery Bypass Grafts Can Be Fatal: A Case Report. The Egyptian Journal of Cardiothoracic Anesthesia. https://doi.org/10.21608/ejca.2024.388897
Vancouver
Arunkumar A, Kishore R, Rajeev T, Mohammed I, Mohammed I, Jacob A, et al. A Heparin-Induced Thrombocytopenia with Thrombosis in Coronary Artery Bypass Grafts Can Be Fatal: A Case Report. The Egyptian Journal of Cardiothoracic Anesthesia. 2024. doi:10.21608/ejca.2024.388897
BibTeX
@article{Arunkumar2024,
author = {Arunkumar, Arumugam and Kishore, Ravi and Rajeev, Thilak and Mohammed, Ibrahim and Mohammed, Idhrees and Jacob, Aju and Bashi, Velayudhan},
title = {A Heparin-Induced Thrombocytopenia with Thrombosis in Coronary Artery Bypass Grafts Can Be Fatal: A Case Report},
journal = {The Egyptian Journal of Cardiothoracic Anesthesia},
year = {2024},
doi = {10.21608/ejca.2024.388897}
}
EUVIMED